This month, the Department of Health and Human Services unexpectedly dismissed all 17 members of the Immunization Practices Advisory Committee, which advises the Disease Control and Prevention Advisory Committee on vaccine matters. On June 11, the Department announced the appointment of eight new committee members.
This is something that should concern every American.
The 17 individuals who were let go are not just faceless officials. They are respected professionals in their fields—clinicians, researchers, scientists, and public health leaders—who have dedicated their time and expertise over many years to shape national vaccine policy.
Having served in Congress and practiced medicine for decades, we recognize the challenge of earning the trust of patients and constituents. We know how fragile that trust can be, and how easily it can be lost. The Covid-19 pandemic has further eroded public confidence in health authorities. In public health, reliability is crucial, and sudden changes to advisory groups risk damaging the credibility of the health services that aim to protect us.
This move to overhaul the advisory committee on vaccination practices raises further questions at a time when the U.S. is grappling with one of the worst measles outbreaks in years. The Senate has yet to confirm a permanent director for the Centers for Disease Control and Prevention. What America needs now is consistent, science-driven leadership.
The advisory committee is not meant to be political. It comprises independent, unpaid experts who disclose any potential conflicts of interest and recuse themselves from voting when necessary. They take their responsibilities seriously, and we should acknowledge that effort in return.
The committee’s work is essential. It plays a key role in establishing the national vaccination schedule, determining which vaccines insurance should cover, and providing clear, evidence-based guidance to healthcare providers. When public health threats arise, the committee is expected to form working groups quickly to deliver transparent recommendations.
This type of guidance is increasingly critical. Measles outbreaks have now reached over 30 states this year, with West Texas being a major hotspot. CDC reports indicate there have been 1,200 cases—over four times the total from 2024. Tragically, children in the U.S. have died from complications for the first time in over a decade.
At its last meeting in April, the advisory committee also addressed other issues like influenza, RSV, HPV, and meningitis. They received more than 4,000 comments, with many individuals and organizations praising the committee’s transparency and scientific rigor.
Public opinion polls reveal that Americans still value a strong commitment from the U.S. to vaccine innovation and access. Nearly three-quarters of voters believe that ensuring FDA-approved vaccines are available to those who need them should be a top priority. Moreover, more than two-thirds express concern about declining childhood vaccination rates for diseases like measles and polio—ailments we once thought were under control.
It’s crucial for Americans to stay informed about the newly reorganized advisory committee on vaccination practices. Ignoring its significance could lead to unnecessary risks associated with preventable diseases. Given the heightened importance of this board, it’s our responsibility as citizens to closely watch what happens next.
Larry Bucheon served as a representative for Indiana’s 8th Congressional District from 2011 to 2025 and worked as a cardiothoracic surgeon for nearly 20 years. Michael C. Burgess represented Texas’ 26th Congressional District from 2003 to 2025 and was an obstetrician-gynecologist for over 20 years.
